NASDAQ:AXGN

Axogen Stock Insider Trading

Healthcare > Medical - Devices

Buy AXGN

*Your capital is at risk

$39.49

-1.09 (-2.69%)

At Close: Jul 13, 2026

AxoGen Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -32.01. In total, the insiders bought 1.01M and sold 259.83K AXGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-32.01
● Buy	1.01M shares
● Sell	259.83K shares
72% Buy Activity Strong Negative Correlation
Sell Signal Medium Confidence May 07, 2026 Analysis Breakdown: Supported by a negative Insider Power Score of -32.01. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 24, 2026 Buy	Restricted Stock Units A-Award	Burke William P. Mr. Director	Director	4 392 Value: $186.7K
Jun 24, 2026 Buy	Restricted Stock Units A-Award	Wendell Amy Mcbride Director	Director	4 392 Value: $186.7K
Jun 24, 2026 Buy	Restricted Stock Units A-Award	Weiler Kathy Johnson Director	Director	4 392 Value: $186.7K
Jun 24, 2026 Buy	Restricted Stock Units A-Award	Tyndall Joseph A. Director	Director	4 392 Value: $186.7K
Jun 24, 2026 Buy	Restricted Stock Units A-Award	Thomas Paul Director	Director	5 579 Value: $237.2K
Jun 24, 2026 Buy	Restricted Stock Units A-Award	Levine Alan M Director	Director	4 392 Value: $186.7K
Jun 24, 2026 Buy	Restricted Stock Units A-Award	Johnson John Director	Director	4 392 Value: $186.7K
Jun 19, 2026 Buy	Common Stock M-Exempt	Levine Alan M Director	Director	14 150 Value: $558.8K
Jun 19, 2026 Buy	Restricted Stock Units M-Exempt	Levine Alan M Director	Director	14 150 Value: $558.8K
Jun 19, 2026 Buy	Common Stock M-Exempt	Weiler Kathy Johnson Director	Director	14 150 Value: $558.8K
Jun 19, 2026 Buy	Common Stock M-Exempt	Wendell Amy Mcbride Director	Director	14 150 Value: $558.8K
Jun 19, 2026 Buy	Restricted Stock Units M-Exempt	Wendell Amy Mcbride Director	Director	14 150 Value: $558.8K
Jun 19, 2026 Buy	Restricted Stock Units M-Exempt	Tyndall Joseph A. Director	Director	14 150 Value: $558.8K
Jun 19, 2026 Buy	Common Stock M-Exempt	Johnson John Director	Director	14 150 Value: $558.8K
Jun 19, 2026 Buy	Restricted Stock Units M-Exempt	Johnson John Director	Director	14 150 Value: $558.8K
Jun 19, 2026 Buy	Common Stock M-Exempt	Burke William P. Mr. Director	Director	14 150 Value: $558.8K
Jun 19, 2026 Buy	Restricted Stock Units M-Exempt	Burke William P. Mr. Director	Director	14 150 Value: $558.8K
Jun 19, 2026 Buy	Common Stock M-Exempt	Tyndall Joseph A. Director	Director	14 150 Value: $558.8K
Jun 19, 2026 Buy	Restricted Stock Units M-Exempt	Thomas Paul Director	Director	18 867 Value: $745.1K
Jun 19, 2026 Buy	Common Stock M-Exempt	Thomas Paul Director	Director	18 867 Value: $745.1K
Jun 19, 2026 Buy	Restricted Stock Units M-Exempt	Weiler Kathy Johnson Director	Director	14 150 Value: $558.8K
May 08, 2026 Sell	Common Stock S-Sale	Wendell Amy Mcbride Director	Director	1 647 Value: $70.2K
May 08, 2026 Buy	Common Stock M-Exempt	Wendell Amy Mcbride Director	Director	1 647 Value: $24.5K
May 08, 2026 Buy	Employee Stock Option (right to purchase) M-Exempt	Wendell Amy Mcbride Director	Director	1 647 Value: $24.5K
May 07, 2026 Sell	Common Stock S-Sale	Quackenbush Doris Sales Vp	Officer	3 878 Value: $168.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AXOGEN

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for te...

Read Full Profile Here